Don't have a Account?
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission
Welcome Guest | Connect with us
Updated on 15 January 2013
· Paediatric hexavalent vaccine (DTP-Hep B-Polio-Hib): The CHMP opinion is expected in Q1 2013.
· Fluzone QIV IM (quadrivalent inactivated flu vaccine, intramuscular): The FDA decision is expected in Q2 2013.
Get direct access to more such reports. Subscribe to BioSpectrum Bureau
"Your comment has been successfully added. Thank you for your contribution.
Cyber Media may edit your comments and not all comments will be published. Your comments may be published on any Cybermedia service worldwide."
Sign in
Notify me of follow-up comments via e-mail address
Post Comment
What can India do to streamline its regulatory processes?...
How has India been able to keep Polio at bay?
What's with the medtech registration scenario in Taiwan?...
China to up healthcare spending to $1 trillion
BioSpectrum survey: There is gender equality in biosciences...
BioSpectrum Asia honors Asia’s best in bioscience...
Women in life sciences – A peep into the lives of...
Editor's Pick
Featured Links
Survey Box
Ranbaxy Controversy
Will the Ranbaxy controversy end the Indian pharma dominion in the US market?
Send this article by email